Donowitz GR |
Tissue-directed antibiotics and intracellular parasites: complex interaction of phagocytes, pathogens, and drugs. |
1994 |
Clin. Infect. Dis. |
pmid:7893881
|
Jones RN et al. |
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards. |
1994 |
Diagn. Microbiol. Infect. Dis. |
pmid:7924221
|
Carlier MB et al. |
Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. |
1994 |
Int J Tissue React |
pmid:7558665
|
|
Management of genital Chlamydia trachomatis infections. |
1994 |
Drug Ther Bull |
pmid:7635012
|
Steven N et al. |
Corticosteroid therapy for AIDS patients with Mycobacterium avium-intracellulare infection. |
1994 |
AIDS |
pmid:8011231
|
|
[Newly approved specialty drugs in Austria and new knowledge about currently available specialty drugs. Zithromax capsules, dried syrup]. |
1994 |
Wien. Klin. Wochenschr. |
pmid:7975673
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Klemens SP and Cynamon MH |
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979271
|
Schönwald S et al. |
Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia. |
1994 |
Scand. J. Infect. Dis. |
pmid:7747094
|
Schwab JC et al. |
Localization of azithromycin in Toxoplasma gondii-infected cells. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979295
|
|
[Azithromycin--an innovative macrolide antibiotic for 3-day-therapy]. |
1994 |
Immun. Infekt. |
pmid:7982710
|
Bush MR and Rosa C |
Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy. |
1994 |
Obstet Gynecol |
pmid:8008325
|
Eisenberg E and Barza M |
Azithromycin and clarithromycin. |
1994 |
Curr Clin Top Infect Dis |
pmid:8086122
|
Kanatani MS and Guglielmo BJ |
The new macrolides. Azithromycin and clarithromycin. |
1994 |
West. J. Med. |
pmid:8128699
|
Bermudez LE et al. |
Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8067766
|
Marchi M et al. |
[Azithromycin-omeprazole. Treatment for the eradication of Helicobacter pylori]. |
1994 |
Minerva Gastroenterol Dietol |
pmid:8204705
|
Rapp RP et al. |
New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis. |
1994 |
Ann Pharmacother |
pmid:7849341
|
Goldman MP and Longworth DL |
The role of azithromycin and clarithromycin in clinical practice. |
1993 Sep-Oct |
Cleve Clin J Med |
pmid:8403355
|
Weber K et al. |
Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. |
1993 Nov-Dec |
Infection |
pmid:8132365
|
Scaglione F et al. |
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222870
|